Skip to main content
. 2017 Oct 27;16:58–64. doi: 10.1016/j.btre.2017.10.002

Table 1.

Recovery Study.

Analyst Assay Instrument Potency (×105 IU/mg)
130% 115% 100% 85% 70%
1 1 1 7.7852 6.7764 5.5017 4.9011 4.0139
2 2 7.1465 6.2950 5.8276 4.7577 3.9402
3 1 7.4216 6.5590 6.0203 4.9451 4.1253
4 2 7.2003 6.4968 5.7958 4.7743 4.0228
5 1 7.9173 6.5266 5.6373 4.7727 3.8350
6 2 7.4679 6.5898 5.8274 4.9749 4.1294
7 1 7.4625 6.6443 5.5970 4.9066 3.9890
8 2 7.2515 6.4691 5.6157 4.7409 3.9496
2 1 1 7.8943 6.7825 5.9011 4.9491 4.1017
2 2 7.4888 6.7419 5.7973 5.0416 4.2560
3 1 7.5383 6.6131 5.7356 4.9065 4.2273
4 2 7.2667 6.5035 5.6728 4.8413 3.9851
5 1 7.3138 6.5463 5.5661 4.8144 3.8874
6 2 7.3360 6.5947 5.7450 4.8699 4.1428
7 1 7.3950 6.5971 5.5998 4.9234 4.0717
8 2 7.3723 6.6256 5.4948 4.9459 4.0338
3 1 1 7.8821 6.6256 5.6538 4.9285 3.9420
2 2 7.4389 6.4214 5.6608 4.8478 4.0973
3 1 7.0796 6.3387 5.5095 4.7300 3.8839
4 2 7.1578 6.2747 5.6356 4.8739 4.0319
5 1 7.4217 6.6921 5.5307 4.7184 4.0109
6 2 7.8395 6.9471 5.9129 5.0263 4.2174
7 1 6.8343 6.4052 5.2345 4.4942 3.8723
8 2 6.9902 6.4778 5.3741 4.6322 3.9826



Mean Potency 7.41 6.56 5.66 4.85 4.03
Expected Potency 7.54 6.67 5.8 4.93 4.06
Standard Deviation 0.29 0.16 0.18 0.13 0.11
Relative Standard Deviation (%) 4 2 3 3 3
Mean Recovery (%) 98 98 98 98 99

The recovery study was performed by three analysts using two instruments over 8 independent assays. All results are reported from valid assays that passed all system suitability criteria.